<DOC>
	<DOCNO>NCT02138708</DOCNO>
	<brief_summary>The purpose study assess predictive performance pulmonary vascular reactivity acetylcholine , presence pulmonary arterial hypertension ( estimate 1 year closure shunt ) .</brief_summary>
	<brief_title>Evaluation Pulmonary Vascular Reactivity Test Patients With Pulmonary Arterial Hypertension Cardiac Shunt</brief_title>
	<detailed_description>Pulmonary arterial hypertension ( PAH ) important cause mortality morbidity patient congenital heart disease shunt . These congenital cardiac shunt responsible PAH , evolve towards higher pulmonary vascular resistance close early . Patients significant pulmonary flow low pulmonary vascular resistance fully benefit surgical shunt closure complete disappearance pulmonary hypertension closure . In contrast , patient low pulmonary flow high pulmonary vascular resistance benefit keep deleterious pulmonary hypertension closure shunt . In certain situation , especially late discovery heart disease , issue operability patient crucial closing shunt inappropriately worsen spontaneous prognosis . Currently , case doubt operability , several clinical hemodynamic criterion use empirically , predictive value uncertain . It therefore necessary stratify patient operable inoperable group improve overall outcome surgery . In research project propose assess predictive performance pulmonary vascular reactivity acetylcholine test presence elevate PAH 1 year closure shunt . This reactivity test evaluate population patient decision surgical closure shunt adjudicate basis exploration usual test ( therefore blind knowledge result reactivity test ) . The test study design repeat injection increase dos continuous flow acetylcholine leave low lobe pulmonary artery . The last injection consist adenosine inhale O2/NO ( potentiate effect ) maximum vasodilatation . The parameter interest Doppler flow velocity pulmonary artery endothelium-dependent vasodilation acetylcholine relative speed maximum vasodilatation ( adenosine + nitric oxide ( NO ) inhalation )</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Acetylcholine</mesh_term>
	<criteria>Patient child adult , ( regardless age weight ) , present heart disease shunt , Patient require , current care , hemodynamic exploration catheterization ass pulmonary vascular resistance ( due doubt operability patient usual clinical echo cardiographic data ) . Informed consent sign patient least one holder parental authority , investigator Patient affiliate benefit social security scheme Patient specific treatment PAH ( prostacyclin derivative , antagonist endothelium receptor inhibitor phosphodiesterase 5 ) . Patient participate another research exclusion period Known allergy acetylcholine adenosine Contraindication use KRENOSIN ( adenosine ) atrioventricular block second third degree , exception patient cardiac pacemaker . dysfunction sinoatrial ( headset disease ) except patient pacemaker chronic obstructive pulmonary disease bronchospasm ( eg bronchial asthma ) long QT Syndrome severe arterial hypotension know adenosine hypersensitivity Pregnant patient childbearing potential use effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Pulmonary arterial hypertension ,</keyword>
	<keyword>congenital heart disease ,</keyword>
	<keyword>heart shunt ,</keyword>
	<keyword>acetylcholine</keyword>
	<keyword>Pharmacological test pulmonary vascular reactivity ( acetylcholine )</keyword>
</DOC>